Antimicrobial Pharmacokinetics/dynamics Bedside ... - SWAB

More documents

Recommendations

Info

Pharmacodynamic Indices predictive forefficacyT > MIC Cmax / MIC AUC 0-24 / MICTime-dependent Concentration-dependent Concentrationdependentwith timedependencePenicillins Aminoglycosides AminoglycosidesCephalosporins Fluoroquinolones FluoroquinolonesCarbapenems Metronidazole MetronidazoleMonobactams Daptomycin QuinupristinMacrolidesLincoamidesLinezolidAzithromycinGlycopeptidesTetracyclines
Use of ciprofloxacin in the critical care settingFrequently used in critical caresettingEspecially in patients with renalfailure (relative aminoglycosidecontra-indication)Used for gram-negative infectionswith coverage of P. aeruginosainfectionsMIC levels for gram-negativepathogens can vary markedlyDosages of 400 mg bid IV arerecommended for severeinfectionsCiprofloxacin
Page 1 and 2: Antimicrobial Pharmacokinetics/dyna
Page 3 and 4: Inappropriate therapy and VAP morta
Page 5 and 6: Antibiotic dosing strategies in ren
Page 7 and 8: SepsisIncreased CardiacOutputLeaky
Page 9 and 10: Continuous Renal Replacement Therap
Page 11 and 12: Basic principlesExtracorporeal clea
Page 13: Efficacy and PharmacodynamicsDrug l
Page 17 and 18: Quinolones: AUC/MIC > 125AUC above
Page 19 and 20: AUC 1-241ciprofloxacin 2 x 400 mg I
Page 21 and 22: Simulated fractional attainment of
Page 23 and 24: β-lactam static effects: streptoco
Page 25 and 26: More antibiotic specific: T > MIC f
Page 27 and 28: Randomised, prospective, open singl
Page 29 and 30: Systematic review on clinical benef
Page 31 and 32: Total costs of intravenous antibiot
Page 33 and 34: The jury is still out on continuous
Page 35 and 36: Pk during CVVH various antibiotics3
Page 37 and 38: Risk of underdosingHydrophylic anti
Page 39: Thank you!Arthur van Zantenzantena@

Antimicrobial Pharmacokinetics/dynamics Bedside ... - SWAB

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?